examining the combination of egfr inhibition plus chemotherapy in lung cancer
Published 4 years ago • 200 plays • Length 1:18Download video MP4
Download video MP3
Similar videos
-
6:23
frontline chemo and tki combination in egfr nsclc
-
3:35
novel egfr inhibitor combinations for nsclc
-
20:24
targeted treatment with egfr tkis: front line options
-
58:24
time for even more precision in testing and treatment of egfr-mutated nsclc
-
20:34
2021 west oncology | lung cancer | egfr mutation therapy resistance and adcs and trop2
-
2:38
combining bevacizumab with egfr tkis in lung cancer
-
2:02
understanding egfr resistance in patients with met-amplified nsclc
-
0:50
targeted option for non-small cell lung cancer #2023 #oncology #lungcancer
-
2:01
checkmate-722: investigating the addition of immunotherapy to chemotherapy in egfr-mutant nsclc
-
0:50
treating patients with egfr-mutant lung cancer with targeted therapies
-
20:07
acquired egfr resistance: what are the current therapeutic strategies?
-
4:02
treatment of egfr mutated nsclc - 2022 program: targeted therapies forum - english
-
59:19
precision oncology in early-stage lung cancer, with adjuvant egfr-targeted therapy leading the way
-
3:31
osimertinib plus gefitinib for treatment of egfr-mutated non-small cell lung cancer
-
2:54
pembrolizumab or egfr tyrosine kinase inhibitors in nsclc?
-
16:45
amivantamab in combination with lazertinib for osimertinib-relapsed, chemo-naïve egfrm nsclc
-
1:59
treatment options for egfr-positive lung cancer
-
4:49
tatton trial – savolitinib plus osimertinib in egfr-mutated, met-amplified nsclc | lecia sequist
-
1:02:40
new milestones and changing standards of care in early egfr-mutated nsclc